Celebrating Leadership in Parkinson's Research
On November 16, 2026, Dr. Tatiana Foroud, a prominent figure in genetic and neurodegenerative disease research, was awarded the prestigious Robert A. Pritzker Prize for Leadership in Parkinson's Research. The award, administered by The Michael J. Fox Foundation for Parkinson's Research (MJFF), recognizes outstanding contributions to the understanding and treatment of Parkinson’s disease (PD).
A Commitment to Parkinson’s Research
Dr. Foroud holds the distinguished title of Executive Associate Dean for Research Affairs at the Indiana University School of Medicine. With a storied career dedicated to advancing our understanding of Parkinson’s disease, she has played an instrumental role in various key initiatives aimed at enhancing the understanding of the genetics and biomarkers associated with PD. Under her leadership, significant strides have been made in establishing collaborative systems that facilitate genetic discovery and therapeutic development.
The Role of Dr. Foroud and Her Vision
Dr. Foroud has been pivotal in leading major biorepository efforts that contribute vital resources for researchers in the field. As part of MJFF's groundbreaking Parkinson's Precision Medicine Initiative (PPMI), she has worked tirelessly as the genetics chair to ensure that biosample collections are used consistently alongside clinical and genetic data. This multifaceted approach aims to deepen our understanding of the biology of Parkinson's disease.
Her expertise has not only advanced our knowledge base but has also fostered greater involvement among new researchers. "Dr. Foroud's expertise has been critical in helping us launch into this next era of precision medicine for Parkinson's," stated Katie Kopil, PhD, Senior Vice President at MJFF. "Through her mentorship, she ensures that a new generation of scientists engages in this vital field."
Presentation of the Award
The award ceremony took place during MJFF's Fall 2026 Research Roundtable in New York City, coinciding with the Foundation’s annual gala. This event served as a platform for patients and families to engage and learn about the latest research directions spearheaded by MJFF. The prize comes with a $200,000 research grant, designed to further enhance the impact of Dr. Foroud's vital work in Parkinson’s research.
Long-Standing Contributions to the Field
Since receiving her first grant from MJFF back in 2005, Dr. Foroud has contributed to building a robust research infrastructure necessary for studying Parkinson’s genetics and related biology. As a statistical geneticist, her investigations into both common and rare genetic variants related to PD have been groundbreaking, enabling researchers to identify biologically defined groups and pursue more personalized treatment strategies.
One notable project includes her collaborative work on validating a skin-based test that analyzes misfolded alpha-synuclein proteins, a significant marker for Parkinson's disease. This innovation may ultimately allow researchers to track disease progression more accurately and assess the efficacy of new therapies.
Future Directions
In addition to her work with MJFF, Dr. Foroud leads several biorepositories supported by institutions like the National Institutes of Health and local foundations. These efforts are crucial in ensuring a standardized approach to handling samples across various studies, thereby promoting effective genetic and biomarker research.
Expressing her gratitude, Dr. Foroud stated, "I'm deeply honored to receive the 2026 Robert A. Pritzker Award. The progress we are making collectively is a testament to our shared commitment to altering the course of Parkinson's disease."
Understanding the Pritzker Legacy
The Robert A. Pritzker Prize was established in 2011 to honor Robert A. Pritzker, a renowned industrialist living with Parkinson's disease. The prize embodies a commitment to accelerating research and drug development within the PD community, evaluating nominees based on their profound impact on the field.
As the largest nonprofit funder of Parkinson's research worldwide, The Michael J. Fox Foundation remains dedicated to turning the tide on Parkinson's disease through innovative collaborations and relentless advocacy. For more information about their initiatives or to support the cause, please visit
Michael J. Fox Foundation.